System Pages

FDA Approves First ALS Treatment Via Accelerated Approval

April 25, 2023 Comments Off on FDA Approves First ALS Treatment Via Accelerated Approval

Originally posted on ALS.org | April 25, 2023 Washington, D.C. (April 25. 2023) – The ALS Association commends the FDA for approving tofersen under the agency’s accelerated approval pathway for…

Congressional “Dear Colleague” Letter Circulated to Increase Federal Funding for ALS

March 16, 2023 Comments Off on Congressional “Dear Colleague” Letter Circulated to Increase Federal Funding for ALS

Originally posted on ALS.org | March 16, 2023 The U.S. House and Senate are preparing legislation that determines how much will be spent on research. It’s important that ALS research…

ALS Association Submits Public Comments in FDA Review of Toferson

March 8, 2023 Comments Off on ALS Association Submits Public Comments in FDA Review of Toferson

Originally posted on ALS.org | March 8, 2023 The ALS Association submitted comments today to the FDA’s Central and Peripheral Nervous System Advisory Committee, urging it to recommend approval of…